Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Record History now includes a new revision entry for v3.5.4 and removes the previous v3.5.3 entry, updating the page's release notes to reflect the latest versioning of the study record.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page footer revision label was updated from v3.5.2 to v3.5.3, indicating a backend/site release rather than a modification to the clinical trial’s record history or study details.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Study Design and Study Status entries in the latest history versions; a previous entry dated 2026-03-05 was removed.SummaryDifference0.5%

- Check78 days agoChange DetectedFooter now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded a new Study Status entry to the record history and updated the record to revision v3.4.3 on 2026-03-05.SummaryDifference0.5%

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.